Pretreatment and early intratreatment prediction of clinicopathologic response of head and neck cancer to chemoradiotherapy using <sup>1</sup>H‐MRS
Ann D. King(College of American Pathologists), Anil T. Ahuja(Chandka Medical College), Gary M. Tse(Second Hospital of Tianjin Medical University), Kunwar S. Bhatia, Chenxia Hu(Huazhong University of Science and Technology), Jeffrey Wong(Chinese University of Hong Kong), David K. W. Yeung(Chinese University of Hong Kong), Frankie Mo(Chinese University of Hong Kong), Kwok‐Hung Yu(Chinese University of Hong Kong), Alexander C. Vlantis(Chinese University of Hong Kong)
Cited by 20
Related Papers
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591